Medical high-value consumables market is rapidly increasing: B2B service platform Guoke Hengtai has been listed for three years
"We will start the IPO at the right time." Liu Bing, managing director of Guoke Hengtai (Beijing) Medical Technology Co., Ltd. (hereinafter referred to as "Guo Ke Hengtai") said. Guoke Hengtai is positioned as a third-party professional B2B integrated service platform for medical high-value consumables, which has grown rapidly. Liu Bing said that through the efforts of three full fiscal years, Guoke Hengtai's overall revenue level is close to 2 billion yuan, optimistic and confident about the future. The B2B field of pharmaceutical procurement has always been known for its deep water and meat, which has led to the influx of a large number of outside startups. B2B platforms in the pharmaceutical field were more common in the past, such as Jingdong Medicine, unnamed penguins, drug terminal networks, etc., but in the field of high-value consumables, this platform is still rare. On the one hand, the market for medical devices has not yet developed fully in the pharmaceutical market. Take the US market as an example. The market size of devices and drugs is roughly 1:1, while the current situation in China's market is 1:4, and the market space is still developing. On the other hand, the logistics system of high-value consumables and pharmaceuticals is completely different, and there are certain professional barriers in every link of the entire supply chain. For example, in the terminal distribution link, the drug is a one-way logistics, that is, the dealer can deliver the drug to the hospital for direct storage; and the high-value consumable is a two-way logistics, that is, after the surgery of the hospital is completed, the dealer needs to distribute the excess consumables and surgical tools. Take it back; for example, in the basic inventory reserve, because of the high-value medical consumables that require the preparation of a full set of surgical products for different diseases and human characteristics (there are tens of thousands of SKUs for complex surgical product models), then the number of conventional product inventory structures Professional industry knowledge is required for matching and distribution. However, the high-value consumables market has huge growth potential. Taking the cardiovascular and orthopaedic consumables with the largest industry and highest output value as an example, according to the China Cardiovascular Disease Report 2015, the scale of the heart stent market in China alone exceeded 8 billion yuan in 2015, with a growth rate of over 13%. The growth rate is 10%-15%. Another research institute predicts that the current domestic market for trauma, joints and spine consumables is about 19.2 billion yuan. The future joint and spine device market is about 20%, and the trauma device market is 15%. High-value medical supplies are an industry that is growing rapidly, but the traditional dealer system faces many problems. Liu Bing summed up the problem in two aspects. One is that the industry is inefficient, and the other is that the company is under financial pressure. Low efficiency mainly means that the overall concentration of the industry is low, and a large number of small and medium-sized dealers exist, which brings two costs: one is that each dealer needs to build a warehousing and logistics team; the other is that the manufacturer is looking for a new dealer. There are also huge costs and risks. We're professional Resectoscope Electrode
manufacturers and suppliers in China, specialized in providing high
quality medical instruments with reasonable price. We warmly welcome you
to buy or wholesale bulk Resectoscope Electrode for sale here and get quotation from our factory. Resectoscope Electrode,Resectoscope Loop,Bipolar Resectoscope,Resectoscope Working Element Tonglu WANHE Medical Instrument Co., Ltd , https://www.tlvanhurhealth.com